The Intellectual Property Office of the Republic of Serbia has published an accepted patent under the designation RS 66375 B1, the application of which has gone through all legal and technical processes, and the Office has approved it as valid.

The patent entitled HYBRID COMPOUNDS OF SCLAREOL AND DOXORUBICIN, THEIR OBTAINMENT AND APPLICATION is the result of collaborative work of three institutions of the University of Belgrade: IBISS, Faculty of Chemistry and ICTM. The inventors are Dr. Milica Pešić (IBISS), prof. Igor Opsenica (Faculty of Chemistry), Ana Kostić (married Stepanović, IBISS) and Nataša Terzić-Jovanović (ICTM).